Strides Pharma Science is currently trading at Rs. 674.35, up by 19.80 points or 3.02% from its previous closing of Rs. 654.55 on the BSE.
The scrip opened at Rs. 664.95 and has touched a high and low of Rs. 687.00 and Rs. 647.45 respectively. So far 2787576 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 687.00 on 2-Jan-2024 and a 52 week low of Rs. 268.40 on 21-Mar-2023.
Last one week high and low of the scrip stood at Rs. 687.00 and Rs. 634.10 respectively. The current market cap of the company is Rs. 6095.70 crore.
The promoters holding in the company stood at 27.78%, while Institutions and Non-Institutions held 37.16% and 35.06% respectively.
Strides Pharma Science has received an approval for investment in the securities of AMP Energy C&I Six (AMP-6) and AMP Energy C&I Eight (AMP-8). The Management Committee of the Board of Directors of the Company in its meeting held on January 2, 2024, has approved the same.
AMP-6 & AMP-8 are special purpose entities formed for purpose of setting up captive solar power projects in Karnataka. The proposed arrangement is in line with Strides’ commitment to enhance usage of renewable power source in Strides’ operations.
Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1808.50 |
Dr. Reddys Lab | 1342.45 |
Cipla | 1472.45 |
Lupin | 2147.55 |
Zydus Lifesciences | 973.90 |
View more.. |